ProfileGDS5678 / 1417109_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 71% 73% 78% 79% 74% 71% 71% 79% 79% 77% 77% 77% 77% 77% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.4262171
GSM967853U87-EV human glioblastoma xenograft - Control 24.6910573
GSM967854U87-EV human glioblastoma xenograft - Control 35.3982978
GSM967855U87-EV human glioblastoma xenograft - Control 45.6198779
GSM967856U87-EV human glioblastoma xenograft - Control 54.8674
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.4538971
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 24.4168271
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.469479
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.4952779
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.2213577
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 25.2065577
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.2306677
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.224677
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.2486377